Source: BUSINESS JOURNAL, 2/22/17

Bayer AG has hinted that its $66 billion takeover of Creve Coeur-based Monsanto could face delays as regulators request further information on the deal. Bayer originally had targeted the first quarter in which to seek European Union approval for the merger, but CEO Werner Baumann told reporters Wednesday at a meeting in Germany that the company would be pushing that back to the next quarter, Bloomberg reports.

For more of this story, click here.